Left’s Newsletter

Home
Chat
Archive
Leaderboard
About
Moberg Pharma
“Give me a lever long enough and a fulcrum on which to place it, and I shall move the world.” ―Archimedes
 • 
Left
6
New
Top
Community
Cipher Pharmaceuticals - Piclidenoson
An overview of piclidenoson's competitive positioning within the plaque psoriasis landscape
 • 
Left
Pricing change
 • 
Left
Piclidenoson on deck
Upcoming - detailing Cipher Pharmaceuticals least understood growth asset.
 • 
Left
UPDATE - Cipher Pharmaceuticals announces NCIB to repurchase 10% of its public float, Launching paid tier.
 • 
Left
UPDATE: Cipher Pharmaceuticals - Incidental discovery involving piclidenoson in pre-clinical studies for the treatment of Lowe Syndrome
 • 
Left
AirIQ Inc.
A small vertical market software company in the telematics market
 • 
Left
2
A subsidiary of Geo Group Inc. has been supercharged by administrative changes & the border crisis while burgeoning construction costs have…
Geo Group Inc.
 • 
Left
Left’s Newsletter
Investing
Recommendations
View all 7
Philoinvestor
Philoinvestor
Philoinvestor
Jam_invest’s Substack
Jam_invest’s Substack
Jam_invest
Margin of Safety Investing
Margin of Safety Investing
Simon Handrahan
Petty Cash
Petty Cash
Dean
U
Upham’s Investment Blog
Upham

Left’s Newsletter

AboutArchiveRecommendationsSitemap
© 2023 Left Field
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing